Abbott Laboratories
ABT
$105.16
-$0.745-0.70%
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 0.97% | 1.65% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.97% | 1.65% | |||
| Cost of Revenue | -1.61% | 2.72% | |||
| Gross Profit | 3.11% | 0.78% | |||
| SG&A Expenses | -0.88% | -0.69% | |||
| Depreciation & Amortization | -3.02% | -0.40% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.27% | 0.71% | |||
| Operating Income | 16.28% | 6.37% | |||
| Income Before Tax | 7.42% | 2.14% | |||
| Income Tax Expenses | -14.47% | -9.96% | |||
| Earnings from Continuing Operations | 11.00% | 4.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 11.00% | 4.44% | |||
| EBIT | 16.28% | 6.37% | |||
| EBITDA | 10.68% | 5.28% | |||
| EPS Basic | 10.39% | 4.55% | |||
| Normalized Basic EPS | 15.12% | 2.25% | |||
| EPS Diluted | 10.79% | 5.13% | |||
| Normalized Diluted EPS | 15.75% | 2.26% | |||
| Average Basic Shares Outstanding | 0.53% | -0.10% | |||
| Average Diluted Shares Outstanding | -0.02% | -0.11% | |||
| Dividend Per Share | 7.84% | 0.00% | |||
| Payout Ratio | -0.10% | -0.04% | |||
